FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets

83,706 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 48400 - 48600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1466.jsonOptic Atrophyactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1467.jsonOptic Neuritisactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1468.jsonOther and Unspecified Forms of Chorioretinitis and Retinochoroiditisactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1469.jsonOther Background Retinopathy and Retinal Vascular Changesactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1471.jsonOther Disorders of Optic Nerveactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1473.jsonOther Endophthalmitisactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1475.jsonPrior Penetrating Keratoplastyactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1477.jsonPurulent Endophthalmitisactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1478.jsonRetinal Detachment with Retinal Defectactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1479.jsonRetinal Vascular Occlusionactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1480.jsonOther Proliferative Retinopathyactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1482.jsonSeparation of Retinal Layersactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1483.jsonVisual Acuity 20/40 or Betteractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1491.jsonMajor Depressive Disorder Activeactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1492.jsonPsych Visit Diagnostic Evaluationactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1496.jsonPsych Visit Psychotherapyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1530.jsonSpeech and Hearing Evaluationactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1558.jsonMorgagnian Cataractactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1559.jsonMacular Scar of Posterior Polaractive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1560.jsonBest Corrected Visual Acuity Exam Using Snellen Chartactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1561.jsonMedications for Above Normal BMIactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1562.jsonMedications for Below Normal BMIactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1563.jsonUnderweightactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1566.jsonAdult Depression Medicationsactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1567.jsonAdolescent Depression Medicationsactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1568.jsonFollow Up for Adult Depressionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1569.jsonFollow Up for Adolescent Depressionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1570.jsonReferral for Adolescent Depressionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1571.jsonReferral for Adult Depressionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1572.jsonHigh Intensity Statin Therapyactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1573.jsonLDL Cholesterolactive2025-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1574.jsonLow Intensity Statin Therapyactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1575.jsonModerate Intensity Statin Therapyactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1576.jsonOutpatient Encounters for Preventive Careactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1578.jsonFollow Up Within 4 Weeksactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1580.jsonReferral to Primary Care or Alternate Provideractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1581.jsonLifestyle Recommendationactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1582.jsonPatient Declinedactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1583.jsonReferral or Counseling for Alcohol Consumptionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.1584.jsonHospice Care Ambulatoryactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.3000.jsonMetforminactive2019-12ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.319.jsonProstate Canceractive2020-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.320.jsonBone Scanactive2024-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.326.jsonPrimary Open Angle Glaucomaactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.327.jsonDiabetic Retinopathyactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.353.jsonEnd Stage Renal Diseaseactive2020-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.362.jsonAsthmaactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.366.jsonArrhythmiaactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.367.jsonAtrioventricular Blockactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.368.jsonCardiac Pacer in Situactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.369.jsonCoronary Artery Disease No MIactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.370.jsonHypotensionactive2020-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.371.jsonCardiac Surgeryactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.376.jsonHeart Failureactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.378.jsonPregnancyactive2021-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.398.jsonProstate Cancer Treatmentactive2025-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.399.jsonSalvage Therapyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.401.jsonProstate Specific Antigen Testactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.403.jsonInitial Myocardial Infarctionactive2024-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.412.jsonBradycardiaactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.451.jsonPain Warranting Further Investigation for Prostate Canceractive2020-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.471.jsonBilateral Oophorectomyactive2024-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.485.jsonChemotherapyactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.3.509.jsonTobacco Use Cessation Counselingactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1498.jsonMedications for Above Normal BMIactive2025-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1499.jsonMedications for Below Normal BMIactive2022-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1519.jsonFollow Up for Above Normal BMIactive2017-05ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1523.jsonFollow Up for Above Normal BMIactive2017-08ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1524.jsonFollow Up for BMI Outside Normal Parametersactive2024-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1525.jsonFollow Up for Above Normal BMIactive2025-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1526.jsonFollow Up for Above Normal BMIactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1527.jsonReferrals Where Weight Assessment May Occuractive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1528.jsonFollow Up for Below Normal BMIactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1549.jsonFollow Up for Below Normal BMIactive2023-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1550.jsonFollow Up for Below Normal BMIactive2023-02ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1551.jsonFollow Up for Below Normal BMIactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1578.jsonPalliative Careactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1579.jsonPalliative or Hospice Careactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1608.jsonEncounter to Document Medicationsactive2025-01ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1609.jsonEncounter to Document Medicationsactive2025-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1610.jsonReferrals Where Weight Assessment May Occuractive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1751.jsonEncounter to Evaluate BMIactive2024-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1834.jsonEncounter to Document Medicationsactive2024-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.1917.jsonEncounter to Document Medicationsactive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.695.jsonEncounter to Evaluate BMIactive2025-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.885.jsonEncounter to Evaluate BMIactive2018-03ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1.886.jsonEncounter to Evaluate BMIactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1475.jsonReferral to Primary Care or Alternate Provideractive2021-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1476.jsonPharmacologic Therapy for Hypertensionactive2025-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1482.jsonLaboratory Tests for Hypertensionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1497.jsonEncounter to Screen for Blood Pressureactive2024-02ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1508.jsonLifestyle Recommendationactive2025-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1509.jsonWeight Reduction Recommendedactive2022-02ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1510.jsonWeight Reduction Recommendedactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1511.jsonDietary Recommendationsactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1512.jsonDietary Recommendationsactive2025-01ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1514.jsonDietary Recommendationsactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1515.jsonDietary Recommendationsactive2025-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1516.jsonExercise Classactive2017-05ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1518.jsonRecommendation to Increase Physical Activityactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1537.jsonFollow Up Within 4 Weeksactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1538.jsonEncounter to Screen for Depressionactive2025-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1914.jsonEncounter to Screen for Depressionactive2020-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1915.jsonEncounter to Screen for Depressionactive2023-02ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1916.jsonEncounter to Screen for Depressionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1918.jsonEncounter to Screen for Blood Pressureactive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.192.jsonEncounter to Screen for Blood Pressureactive2025-02ushl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.1920.jsonEncounter to Screen for Blood Pressureactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.2387.jsonOverweight or Obeseactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.2388.jsonUnderweightactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.2395.jsonFinding of Hypertensionactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.2462.jsonLaboratory Tests for Hypertensionactive2025-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.2466.jsonDental Tooth Extractionactive2022-02ushl7
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.259.jsonDiagnosis of Hypertensionactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.261.jsonDiagnosis of Hypertensionactive2021-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.263.jsonDiagnosis of Hypertensionactive2024-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.467.jsonFollow Up for Adolescent Depressionactive2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.468.jsonFollow Up for Adult Depressionactive2024-01ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.469.jsonAdolescent Depression Medicationsactive2023-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.470.jsonAdult Depression Medicationsactive2024-02ushl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.537.jsonReferral for Adolescent Depressionactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.538.jsonReferral for Adult Depressionactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.791.jsonPatient Declinedactive2025-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.805.jsonWeight Reduction Recommendedactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.810.jsonRecommendation to Increase Physical Activityactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.600.823.jsonReferral or Counseling for Alcohol Consumptionactive2022-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.6366.117.jsonAbsence of Cervixactive2024-08ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.1743.jsonGeneral or Neuraxial Anesthesiaactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.1940.jsonImmunocompromised Conditionsactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.2262.jsonCABG Surgeriesactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.2328.jsonImmunocompromised Conditions I10active2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.2343.jsonImmunocompromised Conditionsactive2024-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.3011.jsonAcute Myocardial Infarctionactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.3024.jsonAcute Myocardial Infarctionactive2016-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.307.jsonEncounter Inpatientactive2020-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.335.jsonBone Marrow Transplantactive2021-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.336.jsonBone Marrow Transplantactive2024-01ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.404.jsonBone Marrow Transplantactive2024-02ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.623.jsonAcute Myocardial Infarctionactive2024-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.694.jsonCABG Surgeriesactive2024-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.737.jsonPCIactive2018-08ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.747.jsonEndotracheal Intubationactive2017-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.128.jsonBipolar Disorderactive2024-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.246.jsonPersonality Disorder Emotionally Labileactive2024-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.247.jsonPersonality Disorder Emotionally Labileactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.248.jsonPersonality Disorder Emotionally Labileactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.249.jsonPersonality Disorder Emotionally Labileactive2023-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.254.jsonDysthymiaactive2022-02ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.256.jsonDysthymiaactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.257.jsonDysthymiaactive2023-03ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.262.jsonDeceasedactive2014-05ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.263.jsonPHQ 9 and PHQ 9M Toolsactive2022-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.269.jsonHepatitis Bactive2017-08ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.271.jsonHepatitis Bactive2017-05ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.272.jsonHepatitis Bactive2023-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.43.jsonBipolar Disorderactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.44.jsonBipolar Disorderactive2025-02ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.1.45.jsonBipolar Disorderactive2022-02ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.11.721.jsonDeceasedactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.67.1.101.11.723.jsonPHQ-9 Toolactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.6929.2.1000.jsonEstimated Glomerular Filtration Rateactive2024-02ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.6929.2.1002.jsonUrine Albumin Creatinine Ratioactive2025-03ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.6929.3.1000.jsonEstimated Glomerular Filtration Rateactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.6929.3.1007.jsonUrine Albumin Creatinine Ratioactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1000.jsonStrabismic Amblyopiaactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1001.jsonStrabismic Amblyopiaactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1002.jsonRefractive Amblyopiaactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1003.jsonRefractive Amblyopiaactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1004.jsonRoutine Ophthalmological Examinationactive2019-09ushl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1005.jsonPediatric Best Corrected Visual Acuity Examactive2019-09ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1006.jsonLogMAR Visual Acuity Examactive2019-09ushl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1007.jsonAphakiaactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1008.jsonAphakiaactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1009.jsonInfantile and Juvenile Cataractactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1010.jsonInfantile and Juvenile Cataractactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1011.jsonCongenital Corneal or Anterior Segment Conditionsactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1012.jsonCongenital Corneal or Anterior Segment Conditionsactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1013.jsonEyelid or Orbital Conditionsactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1014.jsonEyelid or Orbital Conditionsactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1015.jsonColoboma of Optic Discactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1016.jsonColoboma of Optic Discactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1017.jsonHemorrhage of Optic Nerve Sheathactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1018.jsonHemorrhage of Optic Nerve Sheathactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1019.jsonOptic Nerve Hypoplasiaactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1020.jsonOptic Nerve Hypoplasiaactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1021.jsonDisorder of Visual Cortex Due to Underlying Conditionactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1022.jsonDisorder of Visual Cortex Due to Underlying Conditionactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1023.jsonCortical Blindnessactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1024.jsonCortical Blindnessactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1025.jsonCongenital Condition of Retinaactive2019-09ushl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.2.1026.jsonCongenital Condition of Retinaactive2019-09ushl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.3.1000.jsonStrabismic Amblyopiaactive2019-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.3.1001.jsonRefractive Amblyopiaactive2019-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.3.1002.jsonRoutine Ophthalmological Examinationactive2019-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.3.1003.jsonPediatric Best Corrected Visual Acuity Examactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.3.1004.jsonLogMAR Visual Acuity Examactive2022-03ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.3.1005.jsonAphakiaactive2019-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.3.1006.jsonInfantile and Juvenile Cataractactive2019-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.3.1007.jsonCongenital Corneal or Anterior Segment Conditionsactive2019-09ushl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.8420.3.1008.jsonEyelid or Orbital Conditionsactive2019-09ushl7vsac